Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.

Hietala M, Henningson M, Ingvar C, Jönsson PE, Rose C, Jernström H.

Acta Oncol. 2011 Jan;50(1):134-43. doi: 10.3109/0284186X.2010.484812. Epub 2010 May 25.

PMID:
20500030
2.

Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.

Wyatt G, Sikorskii A, Wills CE, Su H.

Nurs Res. 2010 Jan-Feb;59(1):58-66. doi: 10.1097/NNR.0b013e3181c3bd26.

PMID:
20010046
3.

Neoadjuvant chemotherapy in stage III breast cancer.

Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.

Am Surg. 2005 Jun;71(6):487-92.

PMID:
16044927
4.

Residual risk of breast cancer recurrence 5 years after adjuvant therapy.

Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ.

J Natl Cancer Inst. 2008 Aug 20;100(16):1179-83. doi: 10.1093/jnci/djn233. Epub 2008 Aug 11.

PMID:
18695137
5.

Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.

Johansson P, Fohlin H, Arnesson LG, Dufmats M, Nordenskjöld K, Nordenskjöld B, Stål O; South-East Sweden Breast Cancer Study Group.

Acta Oncol. 2009;48(4):504-13. doi: 10.1080/02841860902718754.

PMID:
19235568
6.

Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.

Lengacher CA, Bennett MP, Kipp KE, Berarducci A, Cox CE.

Oncol Nurs Forum. 2003 Sep-Oct;30(5):811-21.

PMID:
12949594
7.

Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.

Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Mandelblatt JS, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Kushi LH, Hershman DL.

JAMA Oncol. 2016 Sep 1;2(9):1170-6. doi: 10.1001/jamaoncol.2016.0685.

PMID:
27243607
8.

Complementary and alternative medicine use in breast cancer patients in Europe.

Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S, Bruyns I, Fernadez-Ortega P, Panteli V, Margulies A, Gudmundsdottir G, Milovics L, Ozden G, Platin N, Patiraki E.

Support Care Cancer. 2006 Mar;14(3):260-7. Epub 2005 Sep 6.

PMID:
16143871
9.

Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation.

Astin JA, Reilly C, Perkins C, Child WL; Susan G. Komen Breast Cancer Foundation.

J Soc Integr Oncol. 2006 Fall;4(4):157-69.

PMID:
17022924
10.

Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.

Ben-Arye E, Schiff E, Steiner M, Keshet Y, Lavie O.

Int J Gynecol Cancer. 2012 Jan;22(1):146-53. doi: 10.1097/IGC.0b013e318226c614.

PMID:
21912265
11.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226.

PMID:
18073378
12.

Frequency of use of complementary and alternative medicine in women with breast cancer.

Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE.

Oncol Nurs Forum. 2002 Nov-Dec;29(10):1445-52.

PMID:
12432415
14.

Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.

Henderson JW, Donatelle RJ.

Altern Ther Health Med. 2004 Jan-Feb;10(1):52-7.

PMID:
14727500
15.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

16.
17.

Combined modality therapy of stage IIIC breast cancer.

Dienstmann R, Branco LG, Rezende LM, Freitas LC, Lima CF, Rodrigues GJ, Noronha Filho H, Sarmento RB, Small I, Bines J.

Breast J. 2011 May-Jun;17(3):331-3. doi: 10.1111/j.1524-4741.2011.01086.x. Epub 2011 Apr 8. No abstract available.

PMID:
21477173
19.

Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer.

Lengacher CA, Bennett MP, Kip KE, Gonzalez L, Jacobsen P, Cox CE.

Oncol Nurs Forum. 2006 Jan 1;33(1):97-104.

PMID:
16470237
20.

Supplemental Content

Support Center